<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/bcr635.anc" start="12861" end="12871" sStart="12726" offset="135" sid="r8.suggest.v.0245" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="A subset of morphologically identifiable ME cells lacks the expression of nine corresponding immunophenotypic markers, suggesting that, like the epithelial cells, ME cells might also be subject to different normal and pathological alterations, and that alterations in ME cells might significantly affect the functions and biological behavior of the adjacent epithelial cells." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr635.anc" start="7251" end="7257" sStart="null" offset="166" sid="r11.strong.j.0532" wn="1" wnkey="strong%3:00:00::" annotator="vebatchelder" text="The SMA-negative cells in all three cases showed distinct negativity to ER and CK8, in sharp contrast with the overlying epithelial cells that showed strong ER and CK8 positivities (data not shown)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/bcr635.anc" start="9063" end="9069" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="carichter" text="In our study, p63 was replaced with WT-1 for three main reasons: first, p63 is a nuclear protein, which is not easily identifiable in attenuated or compressed ME cells; second, previous studies have &lt;b&gt;shown&lt;/b&gt; that this protein is also expressed in ME-cell-derived neoplasms and tumors with squamous cell differentiation [ 29 ] ; third, our preliminary study had &lt;b&gt;showed&lt;/b&gt; that WT-1 had the same subcellular localization but seemed to be more specific for ME cells, compared with p63 [ 12 ] ." />
  </sentences>
</list>